Biofrontera AG Company Description

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma.

It also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin.

The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Biofrontera AG

Country	Germany
Founded	1997
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	76

Contact Details

Address: Hemmelrather Weg 201 Leverkusen, 51377 Germany
Phone	49 214 87632 0
Website	biofrontera.com

Stock Details

Ticker Symbol	B8FK
Exchange	Deutsche Börse Xetra
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	DE000A4BGGM7
SIC Code	2834

Key Executives

Name	Position
Pilar de la Huerta Martinez	Chief Financial Officer and Member of Executive Board
Ludwig M. Lutter	Member of the Executive Board
Alexander Richardson	Head of UK Sales Team
Dr. Matthias Naumann	Head of Sales and Marketing - Europe
Dr. Montserrat Foguet Ph.D.	Managing Director of Biofrontera UK Ltd.